Light and touch therapies tested for COVID-19 recovery
NCT ID NCT06795841
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two therapies—low-level laser (light) therapy and myofascial release (a hands-on muscle technique)—against standard chest physiotherapy in 102 moderate COVID-19 patients in the ICU. All patients also received a 12-week home telerehabilitation program after discharge. The goal was to see if these treatments could reduce inflammation markers and improve breathing, strength, and fatigue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- low-level laser therapy
- What this could lead to
- If successful, this could point toward a non-drug way to reduce inflammation and speed recovery in hospitalized COVID-19 patients.
- What could go wrong
- This is a small, completed trial with no phase designation, so results may not apply broadly. The outcomes are lab markers and functional tests, not survival or cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Physical Therapy , Beni-Suef University
Banī Suwayf, 62511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.